BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33974932)

  • 1. Part-time cancers and role of melatonin in determining their metabolic phenotype.
    Reiter RJ; Sharma R; Rodriguez C; Martin V; Rosales-Corral S; Zuccari DAPC; Chuffa LGA
    Life Sci; 2021 Aug; 278():119597. PubMed ID: 33974932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching diseased cells from cytosolic aerobic glycolysis to mitochondrial oxidative phosphorylation: A metabolic rhythm regulated by melatonin?
    Reiter RJ; Sharma R; Ma Q
    J Pineal Res; 2021 Jan; 70(1):e12677. PubMed ID: 32621295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin inhibits Warburg-dependent cancer by redirecting glucose oxidation to the mitochondria: a mechanistic hypothesis.
    Reiter RJ; Sharma R; Ma Q; Rorsales-Corral S; de Almeida Chuffa LG
    Cell Mol Life Sci; 2020 Jul; 77(13):2527-2542. PubMed ID: 31970423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Warburg Effect of Melatonin: A Proposed Mechanism to Explain its Inhibition of Multiple Diseases.
    Reiter RJ; Sharma R; Rosales-Corral S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin and Pathological Cell Interactions: Mitochondrial Glucose Processing in Cancer Cells.
    Reiter RJ; Sharma R; Rosales-Corral S; Manucha W; Chuffa LGA; Zuccari DAPC
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer cell metabolism: Rewiring the mitochondrial hub.
    Oliveira GL; Coelho AR; Marques R; Oliveira PJ
    Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166016. PubMed ID: 33246010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New perspectives in melatonin uses.
    Carpentieri A; Díaz de Barboza G; Areco V; Peralta López M; Tolosa de Talamoni N
    Pharmacol Res; 2012 Apr; 65(4):437-44. PubMed ID: 22311380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin in Mitochondria: Mitigating Clear and Present Dangers.
    Reiter RJ; Ma Q; Sharma R
    Physiology (Bethesda); 2020 Mar; 35(2):86-95. PubMed ID: 32024428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative phosphorylation as a target to arrest malignant neoplasias.
    Rodríguez-Enríquez S; Gallardo-Pérez JC; Marín-Hernández A; Aguilar-Ponce JL; Mandujano-Tinoco EA; Meneses A; Moreno-Sánchez R
    Curr Med Chem; 2011; 18(21):3156-67. PubMed ID: 21671858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To betray or to fight? The dual identity of the mitochondria in cancer.
    Zhang X; Su Q; Zhou J; Yang Z; Liu Z; Ji L; Gao H; Jiang G
    Future Oncol; 2021 Feb; 17(6):723-743. PubMed ID: 33459048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential utility of melatonin in the treatment of childhood cancer.
    Chao YH; Wu KH; Yeh CM; Su SC; Reiter RJ; Yang SF
    J Cell Physiol; 2019 Nov; 234(11):19158-19166. PubMed ID: 30945299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin in clinical oncology.
    Bartsch C; Bartsch H; Karasek M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():30-8. PubMed ID: 12019349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin, mitochondria, and the cancer cell.
    Proietti S; Cucina A; Minini M; Bizzarri M
    Cell Mol Life Sci; 2017 Nov; 74(21):4015-4025. PubMed ID: 28785807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin: A Potential Antineoplastic Agent in Breast Cancer.
    Samanta S
    J Environ Pathol Toxicol Oncol; 2022; 41(4):55-84. PubMed ID: 36374962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review on Melatonin's Effects in Cancer: Potential Mechanisms.
    Hanikoglu A; Kucuksayan E; Akduman RC; Ozben T
    Anticancer Agents Med Chem; 2018; 18(7):985-992. PubMed ID: 29173185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review.
    Mortezaee K; Najafi M; Farhood B; Ahmadi A; Potes Y; Shabeeb D; Musa AE
    Life Sci; 2019 Jul; 228():228-241. PubMed ID: 31077716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin: adjuvant therapy of malignant tumors.
    Dziegiel P; Podhorska-Okolow M; Zabel M
    Med Sci Monit; 2008 May; 14(5):RA64-70. PubMed ID: 18443563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin modulates tumor metabolism and mitigates metastasis.
    Reiter RJ; Sharma R; Tan DX; Huang G; de Almeida Chuffa LG; Anderson G
    Expert Rev Endocrinol Metab; 2023; 18(4):321-336. PubMed ID: 37466337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial Oxidative Phosphorylation Function and Mitophagy in Ischaemic/Reperfused Hearts from Control and High-Fat Diet Rats: Effects of Long-Term Melatonin Treatment.
    Dhanabalan K; Mzezewa S; Huisamen B; Lochner A
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):799-811. PubMed ID: 32458321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Potential of Melatonin to Treat Atherosclerosis by Targeting Mitochondria.
    Sun X; Chen L; Gui QJ
    Curr Top Med Chem; 2023; 23(10):848-859. PubMed ID: 36650630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.